These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 31840684

  • 1. Eptinezumab for the treatment of migraine.
    Scuteri D, Corasaniti MT, Tonin P, Bagetta G.
    Drugs Today (Barc); 2019 Nov; 55(11):695-703. PubMed ID: 31840684
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Calcitonin gene-related peptide (CGRP)-targeted therapies as preventive and acute treatments for migraine-The monoclonal antibodies and gepants.
    Chiang CC, Schwedt TJ.
    Prog Brain Res; 2020 Nov; 255():143-170. PubMed ID: 33008505
    [Abstract] [Full Text] [Related]

  • 4. Eptinezumab: First Approval.
    Dhillon S.
    Drugs; 2020 May; 80(7):733-739. PubMed ID: 32266704
    [Abstract] [Full Text] [Related]

  • 5. The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy.
    Raffaelli B, Reuter U.
    Neurotherapeutics; 2018 Apr; 15(2):324-335. PubMed ID: 29616494
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Eptinezumab for the preventive treatment of migraine.
    Villar-Martínez MD, Moreno-Ajona D, Goadsby PJ.
    Pain Manag; 2021 Mar; 11(2):113-121. PubMed ID: 33280422
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
    Edvinsson L, Haanes KA, Warfvinge K, Krause DN.
    Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives.
    De Matteis E, Guglielmetti M, Ornello R, Spuntarelli V, Martelletti P, Sacco S.
    Expert Rev Neurother; 2020 Jun; 20(6):627-641. PubMed ID: 32434430
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Anti-CGRP-based Migraine Medications: A Comprehensive Overview].
    Triller P, Raffaelli B.
    Fortschr Neurol Psychiatr; 2024 Jul; 92(7-08):277-282. PubMed ID: 38547904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.